Alzheimer's disease

被引:485
作者
Blennow, Kaj [1 ]
de Leon, Mony J.
Zetterberg, Henrik
机构
[1] Sahlgrens Univ Hosp, Clin Neurochem Lab, Dept Neurosci & Physiol, SE-43180 Molndal, Sweden
[2] NYU, Sch Med, Ctr Brain Hlth, Dept Psychiat, New York, NY USA
[3] Nathan S Kline Inst Psychiat Res, New York, NY USA
关键词
D O I
10.1016/S0140-6736(06)69113-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Alzheimer's disease is the most common cause of dementia. Research advances have enabled detailed understanding of the molecular pathogenesis of the hallmarks of the disease-ie, plaques, composed of amyloid beta (A beta), and tangles, composed of hyperphosphorylated tau. However, as our knowledge increases so does our appreciation for the pathogenic complexity of the disorder. Familial Alzheimer's disease is a very rare autosomal dominant disease with early onset, Caused by mutations in the amyloid precursor protein and presenilin genes, both linked to A beta metabolism. By contrast with familial disease, sporadic Alzheimer's disease is very common with more than 15 million people affected worldwide. The cause of the sporadic form of the disease is unknown, probably because the disease is heterogeneous, caused by ageing in concert with a complex interaction of both genetic and environmental risk factors. This seminar reviews the key aspects of the disease, including epidemiology, genetics, pathogenesis, diagnosis, and treatment, as well as recent developments and controversies.
引用
收藏
页码:387 / 403
页数:17
相关论文
共 184 条
[41]   Practice parameter: Management of dementia (an evidence-based review) - Report of the Quality Standards Subcommittee of the American Academy of Neurology [J].
Doody, RS ;
Stevens, JC ;
Beck, C ;
Dubinsky, RM ;
Kaye, JA ;
Gwyther, L ;
Mohs, RC ;
Thal, LJ ;
Whitehouse, PJ ;
DeKosky, ST ;
Cummings, JL .
NEUROLOGY, 2001, 56 (09) :1154-1166
[42]   Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain [J].
Dovey, HF ;
John, V ;
Anderson, JP ;
Chen, LZ ;
Andrieu, PD ;
Fang, LY ;
Freedman, SB ;
Folmer, B ;
Goldbach, E ;
Holsztynska, EJ ;
Hu, KL ;
Johnson-Wood, KL ;
Kennedy, SL ;
Kholedenko, D ;
Knops, JE ;
Latimer, LH ;
Lee, M ;
Liao, Z ;
Lieberburg, IM ;
Motter, RN ;
Mutter, LC ;
Nietz, J ;
Quinn, KP ;
Sacchi, KL ;
Seubert, PA ;
Shopp, GM ;
Thorsett, ED ;
Tung, JS ;
Wu, J ;
Yang, S ;
Yin, CT ;
Schenk, DB ;
May, PC ;
Altstiel, LD ;
Bender, MH ;
Boggs, LN ;
Britton, TC ;
Clemens, JC ;
Czilli, DL ;
Dieckman-McGinty, DK ;
Droste, JJ ;
Fuson, KS ;
Gitter, BD ;
Hyslop, PA ;
Johnstone, EM ;
Li, WY ;
Little, SP ;
Mabry, TE ;
Miller, FD ;
Ni, B .
JOURNAL OF NEUROCHEMISTRY, 2001, 76 (01) :173-181
[43]  
Duff Karen, 2004, Briefings in Functional Genomics & Proteomics, V3, P47, DOI 10.1093/bfgp/3.1.47
[44]   Dietary intake of antioxidants and risk of Alzheimer disease [J].
Engelhart, MJ ;
Geerlings, MI ;
Ruitenberg, A ;
van Swieten, JC ;
Holman, A ;
Witteman, JCM ;
Breteler, MMB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (24) :3223-3229
[45]   NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo [J].
Eriksen, JL ;
Sagi, SA ;
Smith, TE ;
Weggen, S ;
Das, P ;
McLendon, DC ;
Ozols, VV ;
Jessing, KW ;
Zavitz, KH ;
Koo, EH ;
Golde, TE .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (03) :440-449
[46]  
Esiri MM, 2001, LANCET, V357, P169
[47]   Therapeutic effects of PKC activators in Alzheimer's disease transgenic mice [J].
Etcheberrigaray, R ;
Tan, M ;
Dewachter, I ;
Kuipéri, C ;
Van der Auwera, I ;
Wera, S ;
Qiao, LX ;
Bank, B ;
Nelson, TJ ;
Kozikowski, AP ;
Van Leuven, F ;
Alkon, DL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (30) :11141-11146
[48]   Cerebral microvascular pathology in aging and Alzheimer's disease [J].
Farkas, E ;
Luiten, PGM .
PROGRESS IN NEUROBIOLOGY, 2001, 64 (06) :575-611
[49]   Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease - A meta-analysis [J].
Farrer, LA ;
Cupples, LA ;
Haines, JL ;
Hyman, B ;
Kukull, WA ;
Mayeux, R ;
Myers, RH ;
PericakVance, MA ;
Risch, N ;
vanDuijn, CM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (16) :1349-1356
[50]   Global prevalence of dementia: a Delphi consensus study [J].
Ferri, CP ;
Prince, M ;
Brayne, C ;
Brodaty, H ;
Fratiglioni, L ;
Ganguli, M ;
Hall, K ;
Hasegawa, K ;
Hendrie, H ;
Huang, YQ ;
Jorm, A ;
Mathers, C ;
Menezes, PR ;
Rimmer, E ;
Scazufca, M .
LANCET, 2005, 366 (9503) :2112-2117